The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis

The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis

Abstract Objectives T regulatory cells (Tregs) are a heterogeneous group of immunoregulatory cells that dampen self‐harming immune responses and prevent the development of autoimmune diseases. In anti‐neutrophil cytoplasmic autoantibody (ANCA) vasculitis, Tregs possess diminished suppressive capacit...

Full description

Bibliographic Details
Main Authors:	Christian Agosto‐Burgos, Eveline Y Wu, Marie A Iannone, Yichun Hu, Susan L Hogan, Candace D Henderson, Kristin B Kennedy, Lauren Blazek, Carolina A Herrera, Dominique Munson, Ronald J Falk, Dominic J Ciavatta, Meghan E Free
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Clinical & Translational Immunology
Subjects:	ANCA vasculitis autoimmune disease Tregs
Online Access:	https://doi.org/10.1002/cti2.1428

Similar Items

Complement Inhibition in ANCA-Associated Vasculitis
by: Vladimir Tesar, et al.
Published: (2022-07-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
by: Ana Teresa Domingos, et al.
Published: (2019-10-01)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
by: Afroditi Maria Konstantouli, et al.
Published: (2022-09-01)

Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01)

B Lineage Cells in ANCA-Associated Vasculitis
by: Ana Merino-Vico, et al.
Published: (2021-12-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

Environmental factors influencing the risk of ANCA-associated vasculitis
by: Wen-Man Zhao, et al.
Published: (2022-09-01)

The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies
by: Agata Walulik, et al.
Published: (2023-12-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
by: Kazuhiro Kitamoto, et al.
Published: (2023-08-01)

Update of Management of ANCA-Associated Vasculitis
by: Hoi San Tang, et al.
Published: (2021-12-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

Compromiso del sistema nervioso en vasculitis asociadas a ANCA
by: María Fernanda Quaglia
Published: (2018-06-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
by: Nankee K. Kumar, AB, et al.
Published: (2024-03-01)

Post-transplantation Presentation of ANCA-associated Vasculitis: Granulomatosis with Polyangitis
by: M A Shafiee, et al.
Published: (2018-10-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management
by: Shangqing Ge, et al.
Published: (2022-09-01)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis
by: C. King, et al.
Published: (2022-08-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
by: Marinchev Liubomir, et al.
Published: (2013-10-01)

Factor reumatoide en vasculitis ANCA asociadas
by: Laura Julieta Sorrentino, et al.
Published: (2022-09-01)

C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis
by: Peter Korsten, et al.
Published: (2023-02-01)

First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
by: Bengang Huo, et al.
Published: (2023-12-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Caecal Ameboma, colorectal malignancy mimicker in young male with ANCA-associated vasculitis
by: Ali Al Lawati, et al.
Published: (2023-01-01)

The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China
by: Jiannan Li, et al.
Published: (2018-10-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients
by: Peining Zhou, et al.
Published: (2022-01-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

The involvement of NETs in ANCA-associated vasculitis
by: Satoka Shiratori-Aso, et al.
Published: (2023-09-01)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
by: Janina Müller-Deile, et al.
Published: (2021-06-01)

Immune Cells Profiling in ANCA-Associated Vasculitis Patients—Relation to Disease Activity
by: Marcelina Żabińska, et al.
Published: (2021-07-01)

Nasal microbiome research in ANCA-associated vasculitis: Strengths, limitations, and future directions
by: Andreas Kronbichler, et al.
Published: (2021-01-01)

A novel 4-dimensional live-cell imaging system to study leukocyte-endothelial dynamics in ANCA-associated vasculitis
by: Catriona A. Walls, et al.
Published: (2020-04-01)

Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus
by: Xin Chen, et al.
Published: (2023-05-01)

ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics
by: Mario Andrea Piga, et al.
Published: (2023-11-01)

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
by: Rocío Redondo-Rodriguez, et al.
Published: (2022-05-01)